RxDoctor Payments DataLook up a doctor →

Michael Palumbo, MD

Allergy · Pittsburgh, PANPI 1083662720

Payments from drug & device makers

$4,450,198in general payments, 2019–2025

Across 1,555 payments — averaging $2861.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$972K
  • Eli Lilly$715K
  • Sanofi$415K
  • GSK$372K
  • Genentech, Inc.$226K
  • Grifols Therapeutics LLC$203K
  • plus $1.5M from 42 others
$12,287in research payments, 2019–2025

Across 17 payments — averaging $722.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$6K
  • Novartis Pharma AG$4K
  • Sanofi US Services Inc.$1K
  • GSK$115

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,450,198 in reported general payments places this provider in the 95th percentile of 25 allergy providers in Pennsylvania.

See all allergy providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$54,578
Medicare patients
273
Services billed
3,651

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy in Pittsburgh

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →